MicroPort CardioFlow Medtech (FRA:72X0) Beneish M-Score: -0.87 (As of Jun. 25, 2026)


FRA:72X0 MicroPort CardioFlow Medtech Corp FRA:72X0
35 GF Score
Price €0.12
GF Value €0.61
Valuation Possible Value Trap
! 11 Warning Signs
View Full Analysis

What is MicroPort CardioFlow Medtech Beneish M-Score?

MicroPort CardioFlow Medtech FRA:72X0 +0.50% 35 Beneish M-Score is -0.87 as of Jun. 25, 2026. GuruFocus rates FRA:72X0 with a GF Score™ of 35/100 and a GF Value™ of €0.61 (Possible Value Trap). The stock has 11 warning signs investors should review. Among 766 Medical Devices & Instruments companies, MicroPort CardioFlow Medtech ranks worse than 90.99% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -0.87 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for MicroPort CardioFlow Medtech's Beneish M-Score or its related term are showing as below:

FRA:72X0' s Beneish M-Score Range Over the Past 10 Years
Min: -3.25   Med: -1.48   Max: 7.25
Current: -0.87

During the past 8 years, the highest Beneish M-Score of MicroPort CardioFlow Medtech was 7.25. The lowest was -3.25. And the median was -1.48.


MicroPort CardioFlow Medtech Beneish M-Score Historical Data

* Premium members only.

The historical data trend for MicroPort CardioFlow Medtech's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MicroPort CardioFlow Medtech Beneish M-Score Chart

MicroPort CardioFlow Medtech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial 1.83 -3.25 -2.08 -2.13 -0.87

MicroPort CardioFlow Medtech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.08 0.00 -2.13 0.00 -0.87

FRA:72X0 vs ABT, SYK, MDT: Beneish M-Score Comparison

For the Medical Devices subindustry, MicroPort CardioFlow Medtech's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MicroPort CardioFlow Medtech Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort CardioFlow Medtech's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where MicroPort CardioFlow Medtech's Beneish M-Score falls into.


FRA:72X0
35GF Score
MicroPort CardioFlow Medtech Corp FRA:72X0
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MicroPort CardioFlow Medtech Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of MicroPort CardioFlow Medtech for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 3.2305+0.528 * 1.0694+0.404 * 1.5679+0.892 * 1.0041+0.115 * 1.2097
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0948+4.679 * -0.023146-0.327 * 3.1826
=-0.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was €73.94 Mil.
Revenue was €48.72 Mil.
Gross Profit was €31.65 Mil.
Total Current Assets was €318.71 Mil.
Total Assets was €571.90 Mil.
Property, Plant and Equipment(Net PPE) was €87.20 Mil.
Depreciation, Depletion and Amortization(DDA) was €12.20 Mil.
Selling, General, & Admin. Expense(SGA) was €33.70 Mil.
Total Current Liabilities was €126.20 Mil.
Long-Term Debt & Capital Lease Obligation was €178.31 Mil.
Net Income was €-16.07 Mil.
Gross Profit was €0.00 Mil.
Cash Flow from Operations was €-2.83 Mil.
Total Receivables was €22.79 Mil.
Revenue was €48.52 Mil.
Gross Profit was €33.71 Mil.
Total Current Assets was €222.46 Mil.
Total Assets was €355.48 Mil.
Property, Plant and Equipment(Net PPE) was €67.22 Mil.
Depreciation, Depletion and Amortization(DDA) was €11.72 Mil.
Selling, General, & Admin. Expense(SGA) was €30.65 Mil.
Total Current Liabilities was €57.64 Mil.
Long-Term Debt & Capital Lease Obligation was €1.83 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(73.936 / 48.716) / (22.794 / 48.519)
=1.517694 / 0.469795
=3.2305

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(33.711 / 48.519) / (31.651 / 48.716)
=0.6948 / 0.649704
=1.0694

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (318.709 + 87.197) / 571.897) / (1 - (222.46 + 67.218) / 355.482)
=0.290246 / 0.185112
=1.5679

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=48.716 / 48.519
=1.0041

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(11.721 / (11.721 + 67.218)) / (12.2 / (12.2 + 87.197))
=0.148482 / 0.12274
=1.2097

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(33.695 / 48.716) / (30.653 / 48.519)
=0.691662 / 0.631773
=1.0948

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((178.308 + 126.204) / 571.897) / ((1.831 + 57.643) / 355.482)
=0.53246 / 0.167305
=3.1826

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-16.071 - 0 - -2.834) / 571.897
=-0.023146

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

MicroPort CardioFlow Medtech has a M-score of -0.97 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -0.87 mean?
MicroPort CardioFlow Medtech (FRA:72X0) has a Beneish M-Score of -0.87 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on MicroPort CardioFlow Medtech and its competitors. According to the industry distribution chart, MicroPort CardioFlow Medtech ranks #697 out of 766 companies in the Medical Devices & Instruments industry, placing it in the top 91%.
Is MicroPort CardioFlow Medtech's Beneish M-Score too high?
MicroPort CardioFlow Medtech's current Beneish M-Score is -0.87. Based on the distribution chart, MicroPort CardioFlow Medtech ranks #697 out of 766 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, MicroPort CardioFlow Medtech has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MicroPort CardioFlow Medtech's Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MicroPort CardioFlow Medtech ranks #697 out of 766 companies for Beneish M-Score. This places MicroPort CardioFlow Medtech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on MicroPort CardioFlow Medtech and its competitors. MicroPort CardioFlow Medtech's current Beneish M-Score is -0.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroPort CardioFlow Medtech stock overvalued right now?
Based on GuruFocus' analysis, MicroPort CardioFlow Medtech (FRA:72X0) is currently considered Possible Value Trap. The stock's GF Value™ is €0.61, compared to a current price of €0.12 — trading 80.3% below its estimated fair value. The current Beneish M-Score is -0.87. MicroPort CardioFlow Medtech's overall GF Score™ is 35/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For MicroPort CardioFlow Medtech (FRA:72X0), the current Beneish M-Score is -0.87 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MicroPort CardioFlow Medtech (FRA:72X0) Overvalued in 2026?

Based on GuruFocus' analysis, MicroPort CardioFlow Medtech stock appears to be undervalued. The current stock price of €0.12 is trading 80.3% below its estimated GF Value™ of €0.61. GuruFocus considers MicroPort CardioFlow Medtech to be Possible Value Trap.

Key valuation signals for FRA:72X0:

  • Beneish M-Score: -0.87
  • GF Value™: €0.61 vs. price of €0.12 (80.3% below fair value)
  • GF Score™: 35/100 with 11 warning signs

No single metric tells the full story. See the FRA:72X0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MicroPort CardioFlow Medtech Business Description

Other Exchanges 02160:Hong Kong
Address No. 501 Niudun Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of VitaFlow, VitaFlow Liberty, Angelguide and AnchorMan. The Group derives revenue from the sales of medical devices through appointed distributors. It derives maximum revenue from PRC.
35GF Score

Get the complete analysis for FRA:72X0

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.12
Price
€0.61
GF Value